期刊文献+

美托洛尔治疗慢性充血性心力衰竭的疗效和安全性 被引量:6

下载PDF
导出
摘要 慢性充血性心力衰竭(CHF)是各种心脏疾病发展的一个终末阶段,也是最主要的死亡原因。美托洛尔是选择性β肾上腺素能受体阻滞剂,近年来已广泛应用于心血管疾病的治疗。因其能直接或间接降低RAS系统的活性,显著改善CHF患者的心肌收缩功能,提高运动耐力,降低住院率,
作者 千里
机构地区 宁波市第七医院
出处 《心脑血管病防治》 2011年第4期316-318,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献4

  • 1刘贞,付军.美托洛尔在慢性心力衰竭治疗中的作用[J].当代医学,2009,15(34):140-140. 被引量:5
  • 2心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:547
  • 3Juul AB, Wettevslev J, Kofoed-Enevoldsen A, et al. The Diabetic Postoperative Mortality and Morbidity (DIPOM)trial: rationale and design of a multieenter, randomized, placebo-controlled, clinical hial of metoprolol for patients with diabetes mellitus who are ilndergoing major noneardiae Surgery [J]. Am Heart J,2004,147(4) :677 - 683.
  • 4Hunt SA. ACC/AHA task force on practice guideline. ACC/AHA 2005 guidelines updapt for the diagnosis and nanagemcnt of chronic heart failure in the sduh[J]. J Am Coll Cardiol,2005,46(6):82- 86.

二级参考文献68

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:59
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
  • 5Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816.
  • 6Elliott PM,Mckenna WJ.Natural history of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/11502&type=A&selectedTitle=4~58.
  • 7Cooper LT.Definition and classification of the cardiomyopathies.[EB/OL][2006-8-2].http://www.utdol.com.beckerproxy.wustl.edu/applica.../6085&type=A&selectedTitle=2~5.
  • 8McKenna WJ.Genetics of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/9673&type=A&selectedTitle=3~58.
  • 9Poliac LC,Barron ME,Maron BJ.Hypertrophic cardiomyopathy.Anesthesiology,2006,104(1):183-192.
  • 10Maron BJ,Seidman JG,Seidman CE.Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.J Am Coll Cardiol,2004,44(11):2125-2132.

共引文献550

同被引文献39

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部